Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

ClinicalTrials.gov ID: NCT03354637

Public ClinicalTrials.gov record NCT03354637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily for 6 Months in Adolescents and Adult Subjects With Stable Patchy Alopecia Areata With Optional Long-Term Open-Label Extension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary: • To assess safety, tolerability and efficacy of 2 dose strengths of ATI-50002 Topical Solution, compared to vehicle in subjects with alopecia areata (AA) Secondary: • To evaluate key clinical outcome assessments

Study identification

NCT ID
NCT03354637
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aclaris Therapeutics, Inc.
Industry
Enrollment
129 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2017 (Actual)
Primary completion
Apr 18, 2019 (Actual)
Completion
Sep 10, 2019 (Actual)
Last update posted
Jun 5, 2020

2017 – 2019

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
Aclaris Investigator Site Encinitas California 92024 —
Aclaris Investigator Site Laguna Hills California 92653 —
Aclaris Investigator Site Redwood City California 94063 —
Aclaris Investigator Site Washington D.C. District of Columbia 20037 —
Aclaris Investigator Site Boynton Beach Florida 33472 —
Aclaris Investigator Site Miami Florida 33136 —
Aclaris Investigator Site Boston Massachusetts 02115 —
Aclaris Investigator Site Clinton Township Michigan 48038 —
Aclaris Investigator Site Warren Michigan 48088 —
Aclaris Investigator Site Fridley Minnesota 55432 —
Aclaris Investigator Site Minneapolis Minnesota 55455 —
Aclaris Investigator Site Omaha Nebraska 68144 —
Aclaris Investigator Site New York New York 10155 —
Aclaris Investigator Site Durham North Carolina 27710 —
Aclaris Investigator Site Winston-Salem North Carolina 27104 —
Aclaris Investigator Site Portland Oregon 97210 —
Aclaris Investigator Site Fort Washington Pennsylvania 19034 —
Aclaris Investigator Site Knoxville Tennessee 37922 —
Aclaris Investigator Site Nashville Tennessee 37215 —
Aclaris Investigator Site Austin Texas 78745 —
Aclaris Investigator Site Austin Texas 78759 —
Aclaris Investigator Site San Antonio Texas 78229 —
Aclaris Investigator Site San Antonio Texas 78745 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03354637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 5, 2020 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03354637 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →